•  
     
     
    Type Size
     

    CYR61 regulates BMP-2-dependent osteoblast differentiation through {alpha}v{beta}3 integrin/ILK/ERK pathway

    J Biol Chem. 2010 Jul 30. [Epub ahead of print]

    These authors found that cysteine rich protein 61 (CYR61) significantly increased proliferation and osteoblastic differentiation in MC3T3-E1 osteoblasts and primary cultured osteoblasts. CYR61 enhanced mRNA and protein expression of BMP-2 in a time- and dose-dependent manner. Integrin (alpha)v(beta)3 was critical for CYR61-mediated BMP-2 expression and osteoblastic differentiation. This response was mediated through activation of the (alpha)v(beta)3 integrin/ILK/ERK signaling pathway.

    Authors: Su JL, Chiou J, Tang CH, et. al

    Osteoporosis is one of the most common bone pathologies. A number of novel molecules has been reported to increase bone formation including cysteine rich protein 61 (CYR61), a ligand of integrin receptor, but mechanisms remain unclear. It is known that bone morphogenetic proteins (BMPs)-especially BMP-2-are crucial regulators of osteogenesis. However, the interaction between CYR61 and BMP-2 is unclear. We found that CYR61 significantly increases proliferation and osteoblastic differentiation in MC3T3-E1 osteoblasts and primary cultured osteoblasts. CYR61 enhances mRNA and protein expression of BMP-2 in time- and dose-dependent manner. Moreover, CYR61-mediated proliferation and osteoblastic differentiation are significantly decreased by knockdown of BMP-2 expression or inhibition of BMP-2 activity. In this study, we found integrin alphavbeta3 is critical for CYR61-mediated BMP-2 expression and osteoblastic differentiation. We also found that ILK, which is downstream of the alphavbeta3 receptor, to be involved in CYR61-induced BMP-2 expression and subsequent osteoblastic differentiation through an ERK-dependent pathway. Taken together, our results show that CYR61 up-regulates BMP-2 mRNA and protein expression, resulting in enhanced cell proliferation and osteoblastic differentiation through activation of the alphavbeta3 integrin/ILK/ERK signaling pathway.

    Full Text

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Policies and Procedures for more details